GL1X · GenesisL1 explorer

UniProt Q02373

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Q02373)

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (UniProt Q02373): 40 experimental structures and 1 predicted model on GenesisL1, 3 ligands bound, 55 pockets. Binding sites, druggability and experiment against…

UniProt
Q02373
Protein
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10
Experimental structures
40
Predicted models
1
Ligands
3
Pockets
55 · 24 records with a druggable one

Structures

41 records of Q02373 in the MolNFT archive: 40 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
5LC5Structure of mammalian respiratory complex I, CLASS2electron microscopyp——
5LDWStructure of mammalian respiratory Complex I, class1electron microscopyp——
5LDWStructure of mammalian respiratory complex I, CLASS1electron microscopyp——
5LDXStructure of mammalian respiratory complex I, CLASS3.electron microscopyp——
5O31Mitochondrial complex I in the deactive stateelectron microscopyp—2 (best 0.84)
5O31Mitochondrial complex I in the deactive stateelectron microscopyp——
7DGQActivity optimized supercomplex state1electron microscopyg—2 (best 0.87)
7DGZActivity optimized complex I (closed form)electron microscopyg——
7DH0Activity optimized complex I (open form)electron microscopyg——
7DKFActivity optimized supercomplex state4electron microscopyg2—2 (best 0.90)
7QSDBovine complex I in the active state at 3.1 Aelectron microscopypCDL3 (best 0.87)
7QSDBovine complex I in the active state at 3.1 aelectron microscopypCDL—
7QSKBovine complex I in lipid nanodisc, active-Q10electron microscopypCDL, PC1—
7QSLBovine complex I in lipid nanodisc, active-apoelectron microscopypCDL, PC1—
7QSMBovine complex I in lipid nanodisc, Deactive-ligand (composite)electron microscopypCDL, 3PE3 (best 0.85)
7QSMBovine complex I in lipid nanodisc, deactive-ligand (composite)electron microscopypCDL, 3PE—
7QSNBovine complex I in lipid nanodisc, deactive-apoelectron microscopypCDL—
7QSOBovine complex I in lipid nanodisc, State 3 (Slack)electron microscopypCDL, 3PE—
7QSOBovine complex I in lipid nanodisc, state 3 (slack)electron microscopypCDL, 3PE—
7R41Bovine complex I in the presence of IM1761092, active class i (Composite map)electron microscopypCDL3 (best 0.86)
7R43Bovine complex I in the presence of IM1761092, active class iii (Composite map)electron microscopypCDL—
7R44Bovine complex I in the presence of IM1761092, active class iv (Composite map)electron microscopypCDL3 (best 0.86)
7R45Bovine complex I in the presence of IM1761092, deactive class i (Composite map)electron microscopypCDL2 (best 0.85)
7R46Bovine complex I in the presence of IM1761092, deactive class ii (Composite map)electron microscopypCDL2 (best 0.87)
7R47Bovine complex I in the presence of IM1761092, deactive class iii (Composite map)electron microscopypCDL—
7R48Bovine complex I in the presence of IM1761092, deactive class iv (Composite map)electron microscopypCDL2 (best 0.85)
7R4CBovine complex I in the presence of IM1761092, deactive class v (Composite map)electron microscopypCDL2 (best 0.84)
7R4GBovine complex I in the presence of IM1761092, slack class ii (Composite map)electron microscopypCDL3 (best 0.84)
8Q0AInward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.electron microscopypPC1, CDL2 (best 0.85)
8Q0FInward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.electron microscopypPC1, CDL2 (best 0.85)
8Q0JInward-facing, slack proteoliposome complex I at 3.8 A. Initially purified in DDM.electron microscopyp3PE3 (best 0.85)
8Q0MOutward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.electron microscopypPC1, CDL2 (best 0.84)
8Q1PInward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially…electron microscopypCDL, PC12 (best 0.85)
8Q1UInward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially…electron microscopypCDL, PC1, 3PE2 (best 0.85)
8Q1YOutward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially…electron microscopypPC1, CDL2 (best 0.88)
8Q25Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially…electron microscopypPC1, CDL2 (best 0.86)
8Q46Inward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.electron microscopypPC1, CDL2 (best 0.84)
8Q47Inward-facing, open1 proteoliposome complex I at 2.9 A. Initially purified in LMNG.electron microscopypCDL, PC1, 3PE2 (best 0.88)
8Q49Outward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.electron microscopypPC1, CDL2 (best 0.88)
8Q4AOutward-facing, open1 proteoliposome complex I at 2.6 A. Initially purified in LMNG.electron microscopypCDL, PC12 (best 0.87)
Q02373AlphaFold monomer V2.0 prediction for NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10…predictedA—1 (best 0.40)

Ligands

  • CDL · Cardiolipin · in 29 records
  • PC1 · 1,2-diacyl-sn-glycero-3-phosphocholine · in 13 records
  • 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine · in 7 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.